INTUITIVE SURGICAL INC — Director's Dealing 2023

Apr 25, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2023-04-21

Reporting Person: Rosa David J. (EVP Chief Strategy & Growth Of)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-21	Common Stock	M	54000	$42.6367	Acquired	183276	Direct
2023-04-21	Common Stock	S	40800	$297.9209	Disposed	142476	Direct
2023-04-24	Common Stock	M	54000	$42.6367	Acquired	196476	Direct
2023-04-24	Common Stock	S	40764	$299.1965	Disposed	155712	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-21	Non-Qualified Stock Option (right to buy)	$42.6367	M	54000	Disposed	2023-08-15	Common Stock (54000)	Direct
2023-04-24	Non-Qualified Stock Option (right to buy)	$42.6367	M	54000	Disposed	2023-08-15	Common Stock (54000)	Direct

Footnotes

F1: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 15, 2023.

F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.54 to $299.47 as follows: 9,698 shares sold at $296.54 to $297.54; 25,403 shares sold at $297.55 to $298.53; and 5,699 shares sold at $298.60 to $299.47. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $297.79 to $301.83 as follows: 10,560 shares sold at $297.79 to $298.78; 28,240 shares sold at $298.84 to $299.84; 1,364 shares sold at $299.99 to $300.50; and 600 shares sold at $301.83. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.